Japan Lifeline Co (Japan Lifeline Co) 3-Year EBITDA Growth Rate : 26.80% (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Japan Lifeline Co 3-Year EBITDA Growth Rate?

Japan Lifeline Co's EBITDA per Share for the three months ended in Dec. 2023 was $0.26.

During the past 12 months, Japan Lifeline Co's average EBITDA Per Share Growth Rate was 8.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 26.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 2.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 18.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Japan Lifeline Co was 95.10% per year. The lowest was -25.60% per year. And the median was 7.80% per year.

Competitive Comparison of Japan Lifeline Co's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Japan Lifeline Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Japan Lifeline Co's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Japan Lifeline Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Japan Lifeline Co's 3-Year EBITDA Growth Rate falls into.

Japan Lifeline Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Japan Lifeline Co (OTCPK:JLFNF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Japan Lifeline Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Japan Lifeline Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Japan Lifeline Co (Japan Lifeline Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Japan Lifeline Co Ltd (OTCPK:JLFNF) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

7575:Japan

Address

2-2-20, Higashishinagawa, Tennoz Ocean Square, 25th Floor, Shinagawa-ku, Tokyo, JPN, 140-0002

Website

http://www.jll.co.jp

Japan Lifeline Co Ltd is a medical device company operating in Japan. It is engaged in the trading and manufacturing of medical devices specialized in the cardiovascular field. The company offers medical devices mainly for the treatment of cardiac and vascular diseases. It focuses on providing implantable devices to treat arrhythmias; disposable catheter devices with electrodes for diagnosis and treatment of arrhythmias; prosthetic devices to replace blood vessels and heart valves that lost their functions; and devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities and congenital cardiac diseases.

Japan Lifeline Co (Japan Lifeline Co) Headlines

From GuruFocus

CardioFocus® Announces Full Commercial Launch of HeartLight® System in Japan

By PRNewswire PRNewswire • 07-11-2018